A plethora of presentations
The benefits of quitting
MorphoSys and Incyte sign collaboration and license deal
Analysis pairs up with immunotherapy
Why wait?
Further into oncology and NGS
Targeting cancer with Claudin 6
Activating innate immunity against breast cancer
Reversing resistance
Transgene and BioInvent announce data for BT-001 in solid tumors
The benefits of B cells
A good showing
Report roundup
GMI-1359 goes to Phase 1b
Advancing against avelumab
Acelarin ascends to Phase 3
Positive Phase 1 data for Promitil
Early finish in China for surufatinib
Making gold out of lead
Mapping a new mechanism
Targeting tough tumors
Triple combination study shows promise
So far, so good
TG4010 to be retired
Drugging the undruggable
Cologuard mechanism tested for liver cancer
OB-002 shrinks tumors, bone metastases
A G-NK cell therapy collaboration
Grey Wolf Therapeutics makes £2.5 million in Series A2
Meeting a new mechanism
Focus Feature: Cancer Research News
Hitting the target
It’s never just been about killing or removing tumors; it’s about aiming at them accurately
Special Report on Cancer
Metabolic renaissance?
Drilling to the core of life itself: Researchers go deep into the world of metabolomics to find new therapeutic possibilities with metabo-oncology
Focus Feature: Cancer Research News
At the forefront of cancer research
Researchers look to ‘FLIP’ the script on cancer care, analysts say not to fear so much getting stung by STING—and more
PAGE UTILITIES
PRINT CURRENT PAGE
SEND THIS PAGE TO A COLLEAGUE
CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600 | Fax: 440-331-7563
Home
|
About Us
|
Editor's Choice
|
News
|
Opinion
|
Top 5
|
Video
|
Links
© Copyright 2020 Old River Publications LLC. All righs reserved. | Web site managed and designed by
OffWhite.
